RecruitingPhase 4NCT05746143

The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion

The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion: A Randomized Control Trial

Sponsor

University of Southern California

Enrollment

140 participants

Start Date

Feb 1, 2022

Study Type

INTERVENTIONAL

Conditions

Pain, Postoperative Spine Fusion Lumbar Spine Degeneration Lumbar Spine Spondylosis

Summary

The purpose of this study is to evaluate if peri-operative zolpidem for posterior lumbar spinal fusion improves patient reported outcomes following surgery.

Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Placebo and a drug called Zolpidem Tartrate 10 mg for people with lumbar spine degeneration, lumbar spine spondylosis, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.